What GLP-1 Telehealth Really Costs Over Six Months

The cheapest monthly headline is not necessarily the smallest six-month bill. In our October 6, 2026 check of ten providers, annual prepayments, separate memberships and unresolved renewal terms prevented a defensible, universal all-in ranking. The useful result is a record of what can actually be calculated, what must be paid upfront and which missing fact could change the decision.

My purchasing rule is simple: favor a quote with a complete payment schedule over a lower starting price that leaves the later bills open. This review used public merchant pages and the same-day source checks behind our provider reviews. We did not buy medication or test checkout eligibility. “Unknown” below means the evidence did not establish the amount; it never means free.

Define six months before multiplying

Our comparison window is October 6, 2026 through April 5, 2027, with enrollment on October 6. Cash paid counts every scheduled charge inside that window, including an annual prepayment. A six-month allocation divides a longer purchase across the period for comparison, but does not describe money available in your bank account. We show partial calculations only when their assumptions are explicit; none is a guaranteed treatment quote.

A hypothetical $200 subscription billed on the sixth of each calendar month produces six charges, or $1,200. At the same price every 28 days, charges fall October 6, November 3, December 1, December 29, January 26, February 23 and March 23: seven charges, or $1,400. The last payment buys time beyond the window. Six 28-day supplies provide 168 days, not six calendar months. Billing dates and days of medication supplied therefore need separate columns in your own comparison.

Ten providers, with the arithmetic exposed

CLYR Health: compounded semaglutide starts at $169 for a 28-day vial, with a two-month offer at $304. The product page describes one-time purchases and included shipping. Six-month total: unknown, because continuing-dose purchases and package durations cannot be safely extrapolated from the starter offer. The terms also describe subscriptions and checkout shipping, so obtain the applicable order terms rather than assuming the product headline resolves everything.¹¹⁴

Rex MD: oral Wegovy starts at $349 with medication and provider care bundled. This is a pill offer, not a price for every injectable GLP-1. Six-month total: unknown. Six identical $349 charges would be $2,094, but “starts at” does not establish those six charges, the renewal amount or every patient's treatment. Labs and the exact billing interval remain unverified for this calculation.²

Collective: semaglutide is advertised at $59 monthly, tirzepatide at $69, plus $199 annually after a 21-day membership trial. Six medication charges plus the full membership produce $553 or $613, respectively. These are advertised-component subtotals, not verified all-in totals: the terms discuss a prescription-transmission fee, and its applicability and amount remain unresolved. Dose-independent pricing, clinician support and shipping are advertised; required lab costs and the medication cycle still need confirmation.³⁴

Immortals: the product page advertised semaglutide starting at $167 with quarterly prepayment and dose selectors. Six-month total: unknown. The public offer did not establish which dose receives the floor or the second quarter's bill. Multiplying $167 by six would obscure both uncertainties. Consultation, laboratory and shipping charges were not established sufficiently to enter zeroes.⁵

Klinic: initial self-pay visits start at $99, with follow-ups at $75 and medication separate. An illustrative first visit plus five follow-ups is $99 + (5 × $75) = $474 in visit charges at those rates. Six-month total: unknown, because this is an assumed visit schedule, not a required package; medication, labs, fulfillment and any applicable membership are additional unresolved variables. Its value proposition is access and administrative support, not a medication-inclusive sticker.⁶

Belle: compounded semaglutide starts at $109 monthly. The treatment page describes lower prices for longer supplies, dose-independent pricing, provider support, supplies and shipping. Six-month total: unknown because the product floor does not identify the applicable term and upfront charge. Required lab costs and renewal pricing were not verified. A $109 headline alone does not justify publishing $654 as a six-month cash bill.⁷⁸

Mochi Health: the public offer is $39 for an eligible new member's first month, then $79 monthly; promotional availability varies by state. Six monthly membership charges total $434. Medication and diagnostic services are expressly excluded, so the all-in six-month amount is unknown. Prepaid alternatives exist. Confirm the prescribed product, dose, shipping and laboratory bill separately before comparing this membership subtotal with a medication bundle.⁹

Henry Meds: injectable compounded semaglutide's $197 monthly headline requires twelve months paid upfront. Multiplication gives a $2,364 advertised plan commitment, not $1,182 cash for a six-month trial. The latter is only half-year allocation. Medication, provider access, applicable supplies and shipping are included if prescribed; the applicable dose tier, required labs and final checkout amount remain to be confirmed. We therefore show the commitment, with the complete six-month bill unknown.¹⁰

Ro: the first membership month is $39; ongoing advertised rates range from $74 to $149 monthly according to term, with the $74 rate tied to annual prepayment. Medication is separate. Staying on the $149 monthly renewal option after the $39 first month gives $39 + (5 × $149) = $784 in membership charges. This excludes medication and assumes six monthly charges with no plan changes. The all-in six-month total remains unknown without a drug quote. Provider support and necessary labs appear in the offer, while the terms allow charges for additional services. Do not multiply the lowest membership rate by six and treat the result as a treatment budget.¹¹¹⁵

Eden: six-month total and current comparable price: unknown. The current pricing route did not load in this check. Its accessible terms make checkout the source of fees and subscription cutoff conditions. Older promotional landing pages are insufficient to reconstruct today's renewal bill, dose coverage, lab costs or prepayment. Retaining the unknown is more useful than filling the gap with an attractive historical offer.¹²

Decide with two numbers and an exit date

For each finalist, request the amount charged before the first shipment and a dated schedule through your sixth calendar month. Require the exact medication, formulation and dose assumptions; care, labs, supplies and shipping inclusions; any additional fees; and the next renewal commitment. Then ask what remains payable if treatment ends in month two. A prepaid year can make sense for someone who understands the terms, but a monthly equivalent is poor evidence that the plan suits a short trial.

Keep cancellation and refund terms beside the numbers. Unused medication and unused membership time are different refund questions. Our monthly-cost guide explains price components; the cheapest-provider hub and scoring methodology provide broader comparison context. This ten-provider check does not establish a cheapest winner.

A low bill does not settle suitability

FDA says compounded drugs are not FDA-approved and should be used only when an approved drug cannot meet the patient's medical needs. Price arithmetic cannot establish that suitability.¹³ Ask about covered branded options before assuming cash compounding is the right route; insurance coverage, appealing a denial and Medicare Bridge eligibility address different access situations.

If changing services, use the provider-switching checklist to avoid paying overlapping memberships. For a delivered order, consult vial-label guidance and warm-shipment steps, rather than letting a sunk cost decide whether to use it.

Source check and changes

October 6, 2026: initial ten-provider comparison. Merchant statements support prices and terms; arithmetic is ours. Unverified fees, dose tiers and renewal conditions remain explicit. No personalized quote, clinical approval or independent pharmacy assessment is implied.

For another example of separating membership from medication, see our MEDVi review. Its branded treatment cards list a membership charge plus medication; the review keeps unresolved compounded renewal figures out of an all-in calculation.